|Day Low/High||142.09 / 143.70|
|52 Wk Low/High||120.11 / 148.99|
The market held up from the start to the flag today (or at least until I wrote this at about 3PM. At the hour some slippage seen with sixty minutes of trading to go. The close will, as always, be governed by The Last Program Standing. First bottom...
Female representation among the top 10% of earners at the NAFE top companies increased 2% to 41%, the highest since 2013.
Let's pull the band aid off the charts, carefully.
Biotech investors should keep a close eye on the progress in this huge potential market.
It is a very muddled market, and that demands that we stay patient and wait for greater clarity to develop.
I spent a lot of time on the (respectful) Rosenberg/Kass debate on economic growth and interest rates today: * And Now A Word From Dennis Rosenberg * And Now A Word From Dennis Rosenberg (Part Deux) * And the Rosenberg Empire Strikes Again * Ju...
Despite a long list of negatives, the ursine class has been unable to push the market into a full-blown downtrend.
Stocks closed lower after digesting mixed first quarter earnings data.
"It is always by way of pain one arrives at pleasure." - Marquis de Sade Today's Dow Jones decline is the worst since March 21, 2017 -- pulled down materially by weakness in Johnson & Johnson and Goldman Sachs . Stocks are down for the fourth day ...
Stock extend losses as Goldman Sachs and Johnson & Johnson lead the Dow lower.
I'm keeping an eye out, but there isn't enough support to suggest that now is the time to start buying.
Apple's reported move into bio sensors could lead to even greater heights.
Repatriation of profits would bring in money and tax revenue.
Your round-up of the financial news from around the world.
Goldman Sachs and Bank of America release earnings on Tuesday.
These four stocks are showing short-term gain catalysts and longer-term growth potential.
"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as its vacation time at the Kass household and I want to take a swim with my fam...
It's pretty normal to have profit-taking after such a strong first quarter.
We know that we are in the era when index managers are ascendant.
Weaker dollar may not be bad for Boeing, Johnson & Johnson and Procter & Gamble.
Let me teach you how to Dougie. Consumer confidence is a coincident/lagging indicator. And excitement over the print, is (quite frankly) "first level thinking." As support, check out these two charts of the day -- it's "second level thinking." Snap ...
Britain is the second largest market for Google, generating $7.8 billion primarily from advertising in 2016.
The GOP is scrambling for votes on Obamacare Repeal.
"I had nothing to offer anybody except my own confusion." -- Jack Kerouac So, color me confused. But I will persevere and write "Takeaways!" While a lot didn't make sense, I suspect many traders/investors were caught "offsides." Peter Boockvar do...
Healthcare stocks had a heckuva four-year period of over-performance that ended in the summer of 2015. Since then the Health Care Select Sector SPDR ETF (40% pharma and 15% biotech) has had a series of trading-range moves as sector prices lagged. La...